Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 29 | $42,481,308 |
Sells | 72 | $64,597,727 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Sep 2024 16:45 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 19 Sep 2024 | Sale | 13,823 | 42.3058 | 584,793 | D |
20 Sep 2024 16:45 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 18 Sep 2024 | Sale | 1,476 | 42 | 61,992 | I |
20 Sep 2024 16:45 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 18 Sep 2024 | Sale | 1,177 | 42.0119 | 49,448 | D |
13 Sep 2024 16:36 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 11 Sep 2024 | Sale | 6,351 | 37.7753 | 239,911 | D |
13 Sep 2024 16:36 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 11 Sep 2024 | Sale | 9,274 | 37.3111 | 346,023 | D |
30 Aug 2024 16:04 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 28 Aug 2024 | Sale | 700 | 37.5286 | 26,270 | D |
30 Aug 2024 16:04 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 28 Aug 2024 | Sale | 13,995 | 36.8241 | 515,353 | D |
30 Aug 2024 16:04 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 28 Aug 2024 | Sale | 700 | 37.5357 | 26,275 | D |
30 Aug 2024 16:04 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 28 Aug 2024 | Sale | 14,925 | 36.8001 | 549,241 | D |
23 Aug 2024 17:40 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 21 Aug 2024 | Sale | 14,471 | 39.764 | 575,425 | D |
16 Aug 2024 16:31 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | PRESIDENT AND CEO | 14 Aug 2024 | Sale | 15,625 | 37.5633 | 586,927 | D |
17 May 2024 16:21 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, FINANCE, CHIEF ACCT OFFCR | 16 May 2024 | Sale | 2,500 | 43.029 | 107,573 | D |
17 May 2024 16:21 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, FINANCE, CHIEF ACCT OFFCR | 16 May 2024 | Sale | 18,151 | 42.219 | 766,317 | D |
17 May 2024 16:21 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, FINANCE, CHIEF ACCT OFFCR | 15 May 2024 | Sale | 1,965 | 42.68 | 83,866 | D |
17 May 2024 16:21 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, FINANCE, CHIEF ACCT OFFCR | 15 May 2024 | Sale | 8,221 | 42.17 | 346,680 | D |
12 Apr 2024 16:02 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, FINANCE, CHIEF ACCT OFFCR | 10 Apr 2024 | Sale | 5,714 | 40 | 228,560 | D |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 6,965 | 40.057 | 278,997 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 2,944 | 39.193 | 115,384 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 3,112 | 38.223 | 118,950 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 453 | 40.054 | 18,144 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 203 | 39.197 | 7,957 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 1,505 | 40.057 | 60,286 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 201 | 38.231 | 7,684 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 639 | 39.193 | 25,044 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 672 | 38.223 | 25,686 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 867 | 40.059 | 34,731 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 366 | 39.185 | 14,342 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 387 | 38.224 | 14,793 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 177 | 40.058 | 7,090 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 80 | 39.217 | 3,137 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 78 | 38.195 | 2,979 | I |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 7,361 | 39.251 | 288,927 | D |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 11,648 | 38.125 | 444,080 | D |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 10,988 | 38.652 | 424,708 | D |
05 Apr 2024 21:32 | VERA | Vera Therapeutics Inc | GRANT SEAN | CHIEF FINANCIAL OFFICER | 03 Apr 2024 | Sale | 69,831 | 40.051 | 2,796,801 | D |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 25 Mar 2024 | Sale | 340,000 | 40.5 | 13,770,000 | I |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 22 Mar 2024 | Sale | 413,450 | 40.51 | 16,748,860 | I |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 21 Mar 2024 | Sale | 13,718 | 46.18 | 633,497 | I |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 21 Mar 2024 | Sale | 12,617 | 45.52 | 574,326 | I |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 21 Mar 2024 | Sale | 21,918 | 44 | 964,392 | I |
25 Mar 2024 21:46 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 21 Mar 2024 | Sale | 32,756 | 43 | 1,408,508 | I |
01 Feb 2024 17:58 | VERA | Vera Therapeutics Inc | KATABI MAHA | Director | 30 Jan 2024 | Purchase | 161,290 | 31 | 4,999,990 | I |
12 Jan 2024 21:55 | VERA | Vera Therapeutics Inc | COMMODORE CAPITAL LP | 10% | 10 Jan 2024 | Sale | 1,050,000 | 18 | 18,900,000 | I |
23 Aug 2023 17:59 | VERA | Vera Therapeutics Inc | LIN CELIA | Chief Medical Officer | 21 Aug 2023 | Sale | 1,490 | 16.6547 | 24,816 | D |
23 Aug 2023 17:56 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 21 Aug 2023 | Sale | 5,210 | 16.6562 | 86,779 | D |
23 Aug 2023 17:57 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 21 Aug 2023 | Sale | 1,490 | 16.6558 | 24,817 | D |
23 Jun 2023 16:05 | VERA | Vera Therapeutics Inc | GRANT SEAN | Chief Financial Officer | 23 Jun 2023 | Purchase | 5,000 | 16.6 | 83,000 | I |
22 Jun 2023 16:10 | VERA | Vera Therapeutics Inc | COMMODORE CAPITAL LP | 10% | 20 Jun 2023 | Purchase | 448,217 | 15.169 | 6,799,004 | I |
03 Apr 2023 16:05 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 30 Mar 2023 | Purchase | 2,300 | 7.2395 | 16,651 | I |
30 Mar 2023 16:07 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 28 Mar 2023 | Purchase | 23,908 | 7.2441 | 173,192 | I |
28 Mar 2023 16:05 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 27 Mar 2023 | Purchase | 1,633 | 7.2445 | 11,830 | I |
28 Mar 2023 16:05 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 24 Mar 2023 | Purchase | 1,833 | 7.2405 | 13,272 | I |
21 Mar 2023 16:40 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 20 Mar 2023 | Purchase | 15,252 | 7.2143 | 110,033 | I |
21 Mar 2023 16:40 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 17 Mar 2023 | Purchase | 74,045 | 7.1157 | 526,882 | I |
17 Mar 2023 16:10 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 16 Mar 2023 | Purchase | 60,097 | 7.093 | 426,268 | I |
17 Mar 2023 16:10 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 15 Mar 2023 | Purchase | 32,844 | 7.1249 | 234,010 | I |
14 Mar 2023 16:05 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 10 Mar 2023 | Purchase | 48,003 | 7.1555 | 343,485 | I |
07 Mar 2023 16:07 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 03 Mar 2023 | Purchase | 1,000 | 7.245 | 7,245 | I |
03 Mar 2023 16:07 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 02 Mar 2023 | Purchase | 23,378 | 7.2428 | 169,322 | I |
03 Mar 2023 16:07 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 01 Mar 2023 | Purchase | 100 | 7.25 | 725 | I |
27 Feb 2023 16:07 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 23 Feb 2023 | Purchase | 200 | 7.235 | 1,447 | I |
15 Feb 2023 18:32 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 13 Feb 2023 | Purchase | 10,072 | 7.1972 | 72,490 | I |
13 Feb 2023 16:04 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 09 Feb 2023 | Purchase | 400 | 7.25 | 2,900 | I |
09 Feb 2023 16:36 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 08 Feb 2023 | Purchase | 45,357 | 7.22 | 327,478 | I |
09 Feb 2023 16:36 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 07 Feb 2023 | Purchase | 87,956 | 7.08 | 622,728 | I |
17 Feb 2023 16:17 | VERA | Vera Therapeutics Inc | GRANT SEAN | Chief Financial Officer | 06 Feb 2023 | Purchase A | 14,285 | 7 | 99,995 | D |
17 Feb 2023 16:19 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, Finance, Chief Acct Offcr | 06 Feb 2023 | Purchase A | 5,714 | 7 | 39,998 | D |
09 Feb 2023 16:36 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 06 Feb 2023 | Purchase | 131,602 | 7.03 | 925,162 | I |
08 Feb 2023 19:40 | VERA | Vera Therapeutics Inc | LONGITUDE CAPITAL PARTNERS IV, LLC | 10% | 06 Feb 2023 | Purchase | 1,714,285 | 7 | 11,999,995 | I |
08 Feb 2023 19:32 | VERA | Vera Therapeutics Inc | ENRIGHT PATRICK G | Director , 10% | 06 Feb 2023 | Purchase | 1,714,285 | 7 | 11,999,995 | I |
08 Feb 2023 18:29 | VERA | Vera Therapeutics Inc | SOFINNOVA VENTURE PARTNERS X, L.P. | 10% | 06 Feb 2023 | Purchase | 285,714 | 7 | 1,999,998 | D |
09 Feb 2023 16:36 | VERA | Vera Therapeutics Inc | SEIDENBERG BETH C | Director | 03 Feb 2023 | Purchase | 46,163 | 7.24 | 334,220 | I |
19 Dec 2022 17:01 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 16 Dec 2022 | Sale | 783 | 20.1697 | 15,793 | D |
19 Dec 2022 17:01 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 16 Dec 2022 | Sale | 1,429 | 19.1204 | 27,323 | D |
14 Dec 2022 16:08 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 13 Dec 2022 | Sale | 1,078 | 18.19 | 19,609 | D |
14 Dec 2022 16:08 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 13 Dec 2022 | Sale | 11,733 | 18.2767 | 214,441 | D |
14 Dec 2022 16:08 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 12 Dec 2022 | Sale | 6,900 | 18.2498 | 125,924 | D |
08 Dec 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 07 Dec 2022 | Sale | 494 | 16.47 | 8,136 | D |
21 Nov 2022 16:08 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 17 Nov 2022 | Sale | 2,211 | 15.8436 | 35,030 | D |
21 Nov 2022 16:08 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 17 Nov 2022 | Sale | 1,078 | 15.8606 | 17,098 | D |
10 Nov 2022 16:04 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 09 Nov 2022 | Sale | 494 | 16.54 | 8,171 | D |
20 Oct 2022 16:37 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 18 Oct 2022 | Sale | 2 | 20.3 | 41 | D |
20 Oct 2022 16:37 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 18 Oct 2022 | Sale | 5,298 | 19.4159 | 102,865 | D |
20 Oct 2022 16:37 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 18 Oct 2022 | Sale | 2,212 | 19.3865 | 42,883 | D |
20 Oct 2022 16:37 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 18 Oct 2022 | Sale | 1,078 | 19.4304 | 20,946 | D |
06 Oct 2022 16:04 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 05 Oct 2022 | Sale | 988 | 21.64 | 21,380 | D |
05 Oct 2022 16:05 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 04 Oct 2022 | Sale | 906 | 22.1863 | 20,101 | D |
05 Oct 2022 16:05 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 04 Oct 2022 | Sale | 10,418 | 21.6926 | 225,994 | D |
05 Oct 2022 16:05 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 04 Oct 2022 | Sale | 6,899 | 20.2886 | 139,971 | D |
05 Oct 2022 16:05 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 03 Oct 2022 | Sale | 2,408 | 21.159 | 50,951 | D |
05 Oct 2022 16:05 | VERA | Vera Therapeutics Inc | FORDYCE MARSHALL | President and CEO | 03 Oct 2022 | Sale | 11,369 | 20.385 | 231,757 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 21 Sep 2022 | Sale | 264 | 22.3465 | 5,899 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 21 Sep 2022 | Sale | 910 | 21.1255 | 19,224 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 10,112 | 20.8045 | 210,375 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 2,314 | 20.241 | 46,838 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 334 | 20.9153 | 6,986 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 1,828 | 20.4757 | 37,430 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 100 | 21 | 2,100 | D |
22 Sep 2022 16:06 | VERA | Vera Therapeutics Inc | CURLEY JOANNE | Chief Development Officer | 20 Sep 2022 | Sale | 978 | 20.5442 | 20,092 | D |
08 Feb 2023 16:05 | VERA | Vera Therapeutics Inc | YOUNG JOSEPH R | SVP, Finance, Chief Acct Offcr | 06 Feb 2022 | Purchase | 5,714 | 7 | 39,998 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)